Costs and Expenses of NRX Pharmaceuticals, Inc. from 30 Sep 2024 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: NRX Pharmaceuticals, Inc. quarterly Costs and Expenses in USD history and change rate from 30 Sep 2024 to 30 Sep 2025.
NRX Pharmaceuticals, Inc. Costs and Expenses for the quarter ending 30 Sep 2025 was $4,266,000, a 41% increase year-over-year.
Source SEC data: View on sec.gov

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Change (%)

NRX Pharmaceuticals, Inc. Quarterly Costs and Expenses (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025		$4,266,000	+$1,244,000	+41%	01 Jul 2025	30 Sep 2025	10-Q	14 Nov 2025	2024	Q3
Q3 2024		$3,022,000			01 Jul 2024	30 Sep 2024	10-Q	14 Nov 2025	2024	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.